Lepu Biopharma Co., Ltd. (HKG:2157)
Hong Kong
· Delayed Price · Currency is HKD 4.720
+0.270 (6.07%)
Mar 10, 2026, 1:15 PM HKT
Lepu Biopharma Market Cap
Lepu Biopharma has a market cap or net worth of 8.03 billion as of March 9, 2026. Its market cap has increased by 50.93% in one year.
Market Cap
8.03B
Enterprise Value
8.41B
Revenue
767.54M
Ranking
n/a
PE Ratio
n/a
Stock Price
4.72
Market Cap Chart
Since February 23, 2022, Lepu Biopharma's market cap has decreased from 11.84B to 8.03B, a decrease of -32.19%. That is a compound annual growth rate of -9.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 8.03B | -10.46% |
| Dec 31, 2025 | 8.97B | 100.10% |
| Dec 31, 2024 | 4.48B | -35.85% |
| Dec 29, 2023 | 6.99B | -42.72% |
| Dec 30, 2022 | 12.20B | 3.00% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Abbisko Cayman | 7.99B |
| Alphamab Oncology | 7.60B |
| CK Life Sciences Int'l., (Holdings) | 7.59B |
| CStone Pharmaceuticals | 9.79B |
| Shanghai Haohai Biological Technology | 9.96B |
| HBM Holdings | 10.08B |
| CARsgen Therapeutics Holdings | 6.04B |
| Nanjing Leads Biolabs | 10.71B |